ROYAL BANK OF CANADA

Bank

Position in ELTX — Elicio Therapeutics, Inc.

CIK 1000275 TORONTO, A6

Position in ELTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,732

+$1,487 QoQ

Shares Held

443

+1826.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#44

of 48 holders

Holding Since

Mar 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,116,200,383 across 427 Biotechnology names. ELTX ranks #350 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IONS	Ionis Pharmaceuticals Inc	6,182,479	$490,208,754
2	VRTX	Vertex Pharmaceuticals Inc / Ma	980,259	$486,924,048
3	ALNY	Alnylam Pharmaceuticals, Inc.	875,859	$263,659,830
4	INCY	Incyte Corp	1,132,050	$128,329,182
5	REGN	Regeneron Pharmaceuticals, Inc.	174,515	$108,817,078
6	MRNA	Moderna, Inc.	944,457	$66,140,319
7	INSM	INSMED Inc	416,487	$44,405,840
8	HALO	Halozyme Therapeutics, Inc.	545,761	$42,716,712

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,732	443	+1826.1%	Shares	Defined	2026-08-14
2026-03-31	$245	23	-89.5%	Shares	Defined	2026-05-15
2025-12-31	$1,743	219	-99.4%	Shares	Defined	2026-02-17
2025-03-31	$225,067	36,537	+46742.3%	Shares	Defined	2025-11-21
2023-12-31	$650	78	+36.8%	Shares	Defined	2024-02-14
2023-09-30	$481	57	—	Shares	Defined	2023-11-14
2022-09-30 ANGN	—	458	+181.0%	Shares	Defined	2022-11-14
2022-06-30 ANGN	—	163	-87.8%	Shares	Defined	2022-08-15
2022-03-31 ANGN	—	1,337	-75.3%	Shares	Sole	2022-05-16
2021-12-31 ANGN	—	5,404	+101.0%	Shares	Defined	2022-02-14
2021-09-30 ANGN	—	2,688	+577.1%	Shares	Defined	2021-11-15
2021-06-30 ANGN	—	397	-29.6%	Shares	Sole	2021-08-16
2021-03-31 ANGN	—	564	—	Shares	Defined	2021-07-20
No filing history on record for this holder in this stock.